BridgeMD
Compares treatment options for Androgenic Alopecia
Official title Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia
ClinicalTrials.gov ID: NCT07502976
What this study is testing
What is Topical 2-Deoxy-D-ribose Hydrogel?
Topical 2-Deoxy-D-ribose Hydrogel is an investigational medicine, given as an once-daily treatment applied to the skin, being studied as a potential treatment for androgenic alopecia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Androgenetic alopecia is a common form of hair loss that can affect quality of life. This randomized controlled trial aims to evaluate the efficacy and safety of topical 2-Deoxy-D-ribose (2dDR) hydrogel compared with topical minoxidil 5% solution in the treatment of mild to moderate androgenetic alopecia in adults aged 18 to 50 years.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50
You may be able to join if
- Adults aged 18 to 50 years.
- Male and female patients with androgenetic alopecia.
- Mild to moderate disease severity, defined as Hamilton-Norwood scale II to V in males and Ludwig scale I to II in females.
- Ability and willingness to provide written informed consent.
You likely can't join if
- Other types of hair loss, including inflammatory or scarring alopecia.
- Psoriasis.
- Inflammatory scalp dermatoses.
- History of severe systemic disease, including renal, cardiovascular, or hepatic disease.
- Chemotherapy during the last 5 years.
- Pregnancy.
See the full eligibility criteria
- Adults aged 18 to 50 years.
- Male and female patients with androgenetic alopecia.
- Mild to moderate disease severity, defined as Hamilton-Norwood scale II to V in males and Ludwig scale I to II in females.
- Ability and willingness to provide written informed consent.
- Other types of hair loss, including inflammatory or scarring alopecia.
- Psoriasis.
- Inflammatory scalp dermatoses.
- History of severe systemic disease, including renal, cardiovascular, or hepatic disease.
- Chemotherapy during the last 5 years.
- Pregnancy.
- Lactation.
- Bleeding disorders.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Cairo Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Cairo Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.